ForeAccumulation II 7-Year with Growth Accelerator (Morgan Stanley) review

Yes, for the right buyer — and that buyer works with Morgan Stanley. For a client in that channel who wants a mid-duration accumulation FIA with a premium enhancement and no income rider, this is a competitive option. The caps in the 11.50%–11.75% range are reasonable for a 7-year design, and the Growth Accelerator is a meaningful differentiator if the current bonus percentage holds up. The main reservations are the 7-year commitment, the narrow index menu relative to the open-market version, and the incomplete bonus disclosure. If you can get the current rate sheet and the bonus terms are still intact, this is a good accumulation contract for buyers already in the Morgan Stanley ecosystem. If you need broader index access or cannot work through Morgan Stanley, the open-market ForeAccumulation II 7-Year with Growth Accelerator may serve better.

The main reason to buy this product is accumulation with downside protection over a 7-year horizon, with the Growth Accelerator providing an immediate account value boost that compounds through the crediting period. A buyer who contributes $100,000 and receives a meaningful premium enhancement starts the 7-year accumulation window with more working capital than they paid in — that head-start can matter through several annual index credits. The secondary reason is simplicity: two indices, one crediting method, no income rider complexity to track or budget around. For a Morgan Stanley client who wants a clean mid-term growth contract with principal protection, that straightforward design is genuinely appealing.

I think this product is best for a Morgan Stanley client in pre-retirement or early retirement, typically ages 50–75, who wants to dedicate a portion of their portfolio to 7-year principal-protected accumulation with a premium bonus. It suits both qualified and non-qualified accounts, given the 10% free-withdrawal provision and typical RMD-friendly treatment. It is a poor fit for someone who needs guaranteed lifetime income — there is no income rider here — or for someone who wants a broader selection of crediting strategies. It is also the wrong product for anyone without a Morgan Stanley advisory relationship, since that channel requirement is non-negotiable on this version.

You are not buying direct stock market participation. You are buying a 7-year insurance contract that credits interest based on the annual performance of the S&P 500 or MSCI EAFE, subject to annual caps, while protecting your principal from market downturns. The Growth Accelerator adds an upfront premium enhancement — a percentage bonus that increases your account value above what you paid in from day one. In exchange, you accept a 7-year surrender schedule and a market value adjustment that can affect the real cost of early withdrawals. The actual purchase is the combination of principal protection, a boosted starting balance, and structured index access over a mid-term accumulation runway.

ForeAccumulation II 7-Year with Growth Accelerator uses annual point-to-point crediting tied to two indices: the S&P 500 and the MSCI EAFE. Each year, the contract measures the percentage change from the index level at the start of the measurement period to the level at the end, then credits interest up to the cap — currently 11.75% for the S&P 500 strategy and 11.50% for the MSCI EAFE strategy, effective March 2026. If the index is flat or negative, no interest is credited but the account value does not lose ground. That floor at zero is the principal protection mechanism.

The participation rate is guaranteed at 100%, which means the full measured index return counts toward the cap calculation rather than being scaled down by a participation haircut before the cap applies. A 1.25% spread also applies, which means the crediting formula subtracts that amount from the measured index return before applying the cap. Understanding that spread is important: in a year when the S&P 500 returns 6%, the net figure before the cap is 4.75%, not 6%. Caps and spreads can be adjusted by Forethought at each annual reset — today's rates are not guaranteed beyond the current term.

The Growth Accelerator is the secondary feature and the primary reason this version exists alongside the base ForeAccumulation II 7-Year. It applies a premium enhancement — a percentage bonus on your premiums — at contract issue, immediately increasing your starting account value above your out-of-pocket contribution. Over seven years, a meaningful bonus compounds through annual index credits, which is how the feature creates value beyond its face value alone.

The transparency gap is real: the current bonus percentage is not disclosed in the brochure materials reviewed here. That is an unusual omission for a feature that is central to this version's positioning. Before purchasing, ask your Morgan Stanley advisor for the current Growth Accelerator rate sheet, and also ask whether the bonus is subject to a vesting schedule or recapture if you surrender during the 7-year charge period. Those answers determine whether the premium enhancement is as valuable as the name implies.

This annuity is designed for mid-term money. Free withdrawals are available up to 10% of premiums paid in year one and 10% of account value from year two onward. Amounts above the free threshold are subject to the 7-year schedule shown below — starting at 8% in years one and two, then stepping down from 7% to 3% through years three to seven, before dropping to zero. A market value adjustment — MVA — also applies to withdrawals that exceed the free amount, meaning the effective cost of an early exit can move up or down depending on interest rates at the time you withdraw.

Forethought provides surrender charge waivers for nursing home confinement and for terminal illness, which offer meaningful protection in serious health events. RMDs attributable to this contract are typically treated in a way that avoids surrender charges, which matters for IRA owners who expect to begin distributions during the 7-year surrender period. Even with those provisions, this should not be treated as liquid money. Buyers who might need access to more than 10% of their account balance within the next several years should think carefully before committing to this schedule.

The base contract carries no stated annual fee. The Growth Accelerator rider itself functions as a premium enhancement rather than an ongoing fee-based rider in the traditional sense — confirm the exact fee structure with your Morgan Stanley advisor, as the available materials do not specify an ongoing annual charge for this feature. An Enhanced Death Benefit option is available and, if elected, carries an annual fee that varies by issue age — the 10-year Morgan Stanley sibling discloses 0.75% for buyers age 0–70 and 1.20% for buyers age 71–80; confirm whether those figures apply here as well.

The structural tradeoffs are worth naming directly. Upside is limited by caps that reset annually. The 1.25% spread reduces the net index return before the cap applies — a real drag in moderate-return years. The index menu is limited to two benchmarks, which is simpler but also less flexible than the open-market version of this product. The MVA means early exit costs are not fixed. And the Growth Accelerator's bonus terms — the feature that differentiates this version — are not fully disclosed in the available materials, which makes comparison shopping harder than it should be.

Legal Entity: Forethought Life Insurance Company

Parent: Global Atlantic Financial Group